Microbicide Trials Network

MTN-037

Details

Protocol Title: 
A Phase 1 Safety and Pharmacokinetic Study of PC-1005 (MIV-150/Zinc Acetate/Carrageenan Gel) Administered Rectally Using a Sequential Dose/Volume Escalation Method to HIV-1 Seronegative Sexually Abstinent Adults
DAIDS Protocol ID: 
35122
Status: 
In Development

Protocol Chair(s)

Craig Hendrix (Protocol Chair)

Description

MTN-037 is a Phase 1, open label, sequential dose/volume escalation study designed to evaluate the safety and pharmacokinetics of PC-1005 (MIV-150/Zinc Acetate/Carrageenan gel) when administered rectally in men. 

Other Study Info

Sponsor: DAIDS

 

Collaborator: Population Council

 

Study Design: Phase 1, open label, sequential dose/volume escalation trial